Phase 3 clinical trials of the vaccine was an event-driven analysis of 130 symptomatic COVID-19 cases, reported at least two weeks after the second dose, conducted at 25 sites across India.from Top India News- News18.com https://ift.tt/3jBqTdZ
ref=da&site=blogger">IFTTT
No comments:
Post a Comment